Edition:
United States

People: Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

13.73USD
4:00pm EDT
Change (% chg)

$2.66 (+24.03%)
Prev Close
$11.07
Open
$11.68
Day's High
$14.00
Day's Low
$11.45
Volume
1,302,788
Avg. Vol
401,485
52-wk High
$14.00
52-wk Low
$1.48

Waddill, William 

Mr. William D. Waddill has been appointed as Independent Director of the company effective January 1, 2018. William Waddill began his career 30 years ago in commercial banking and public accounting and has been in the biotechnology industry for over 25 years. Currently, he is on the board of Protagonist Therapeutics and most recently was Senior Vice President and CFO of Calithera Bioscience. Prior to Calithera, Mr. Waddill was Senior Vice President and CFO at OncoMed Pharmaceuticals from 2007 to 2014. Mr. Waddill served as the Senior Vice President and CFO of Ilypsa, Inc., a biotechnology company that was acquired in 2007 by Amgen, Inc. Before joining Ilypsa, he served as the founder and principal at Square One Finance, a financial consulting business, and Mr. Waddill served as Senior Director of Finance and Administration at Exelixis, Inc., a biotechnology company. Mr. Waddill received a BS in accounting from the University of Illinois, Chicago, and certification as a public accountant (inactive) after working at PriceWaterhouseCoopers and Deloitte in Boston.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --